Skip to main content

Reactions Weekly

Ausgabe 1/2009

Inhalt (98 Artikel)

Media release

New director at the UMC

Case report

Aciclovir overdose

Case report

Acitretin

Case report

Adalimumab

Case report

Amantadine

Case report

Anticoagulants

Case report

Antiretrovirals

Case report

Antithrombotics

Case report

Aspirin

Case report

Aspirin overdose

Case report

Atorvastatin

Case report

Azathioprine

Case report

BCG vaccine

Case report

Betacarotene

Case report

Betamethasone

Case report

Bevacizumab

Case report

Bevacizumab

Case report

Bleomycin

Case report

Botulinum toxin A

Case report

Bromisoval

Case report

Bupivacaine

Case report

Capecitabine

Case report

Cefaclor

Case report

Cefepime

Case report

Ceftriaxone

Case report

Clarithromycin

Case report

Cyclophosphamide

Case report

Dasatinib

Case report

Duloxetine

Case report

Etanercept/infliximab

Case report

Etoposide

Case report

Glatiramer acetate

Case report

Heparin

Case report

Hepatitis B vaccine

Case report

Herbal medicines

Case report

Herbal medicines

Case report

Hypertonic saline

Case report

Infliximab

Case report

Isotretinoin

Case report

Ketamine overdose

Case report

Lidocaine

Case report

Local anaesthetics

Case report

Methadone

Case report

Methotrexate

Case report

Methotrexate

Case report

Methylprednisolone

Case report

Paclitaxel

Case report

Paroxetine

Case report

Prednisone

Case report

Pregabalin

Case report

Progesterone

Case report

Propafenone

Case report

Propylthiouracil

Case report

Repaglinide

Case report

Sibutramine

Case report

Streptokinase

Case report

Sulphur hexafluoride

Case report

Sunitinib

Case report

Sunitinib

Case report

Tamoxifen

Case report

TJ 12

Case report

Tranylcypromine abuse

Case report

Tretinoin

Case report

Triamcinolone

Case report

Trimethoprim

Case report

Vandetanib

Case report

Varenicline

Case report

Vincristine

Case report

Warfarin

Case report

Ziprasidone